Synexus (United States)

EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study

Vlad Ratziu, Mary E. Rinella, Brent A. Neuschwander‐Tetri et al. · Journal of Hepatology · 2021 · 112 citations

Medicine, Internal Medicine, Pharmacology +2

Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study

The Lancet Infectious Diseases · 2022 · 62 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

Randall Severance, Howard Schwartz, Ron Dagan et al. · Human Vaccines & Immunotherapeutics · 2021 · 20 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Clinical Evaluation of a New, Lower Pain, One Touch Lancing Device for People With Diabetes: Virtually Pain-Free Testing and Improved Comfort Compared to Current Lancing Systems

Mike Grady, Greg Lamps, Ashley Shemain et al. · Journal of Diabetes Science and Technology · 2019 · 17 citations · Full text

Medicine, Internal Medicine, Diabetology +16

Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults

Vianney Tricou, Peter Winkle, Leslie Tharenos et al. · Vaccine · 2023 · 14 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17